no.Neither cannabis nor any other substance is an entry-level drug. There is no switching effect, no pacemakerfunction and no gateway hypothesis
The history of entry-level drug theory
At a plenary session banning marijuana in 1937, Harry J. Anslinger claimed without any scientific evidence that the use of cannabis inevitably leads to the taking of harder drugs at some point.Anslinger was the head of the Federal Bureau of Narcotics. An agency set up by the US Treasury Department whose sole task was to illegalize cannabis.
The U.S. Department of Health and Human Services denied anslinger’s and many other statements and tried to stop the illegalization of cannabis until the very end.Unfortunately, to no avail.
Until his retirement from politics in 1961, Ansinger prevented the research of the various entry-level drug theories that had arisen up to that point.Since then, hundreds of studies and studies have been carried out in this field. And after more than 50 years of research, one thing is clear.
There are no entry-level drugs.
These theories are simply no longer tenable.
And yet government still use it as an excuse for its backward drug policy.
Such an approach was already criticized by the BKA in 1993:
“For a more nuanced view of the problem of addiction, it is essential to uncover myths in the public debate and, as far as possible, to reduce them.
[… However, the cause for myth-making is not only research deficits, but also the ignorance of existing research results. A good example of this is provided by the so-called ” “Entry theory”, i.e. the thesis often in literature that hashish is the entry-level drug into a drug career that inevitably leads to heroin addiction.
This is confirmed by the fact that almost all heroin addicts have previously consumed hashish (as well as alcohol and nicotine).A reversal in such a way that every hashish smoker would automatically become a heroin user, however, cannot be drawn from it [… “This often leads to the misconception that there is a causality, which in reality is only a correlation”. Today, it is assumed that only 1 to 5 % of hashish users later also take hard drugs.” – Drug release: pros and cons
The cannabis experts Prof.Dieter Kleiber and Prof. Renate Soellner writes in “Cannabis 鈥?New Contributions to an Old Discussion”, editor Raphael Ga脽mann (German Centre for Addiction Questions):
“The introducmet is often presented in the political sphere in order to make the dangers of cannabis products comprehensible and this applies, even though it has been criticised by experts for more than thirty years and is now unanimously regarded by experts as empirically unconfirmed. is rejected.”
The German Centre for Addiction Questions, the umbrella organisation of associations and non-profit associations active in addiction care nationwide, distributes together with the BZgA the brochure ” Cannabis – Basic Information“, which states:
“The risk of switching to other “harder” drugs has long been controversially discussed under the heading of “entry drug”.
The observation that almost all heroin addicts had previously smoked cannabis was used as an opportunity to blame cannabis for the switch to heroin. However, what is true for heroin addicts in retrospect does not apply to cannabis users. In fact, only a very small proportion of cannabis users switch to other drugs.”
In 1994, after the scientific literature had been inspected, the Federal Constitutional Court ruled that the thesis of the entry-level drug was “predominantly rejected”.
Prosecutor K枚rner, the author of the authorofthes of the law on today’s Narcotics Act, writes: “The thesis of the transfer effect of hashish (…) has proved to be a myth.”